2006

Innovative Technology Could Represent New Frontier in the Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced enrollment of the...

Company Reports One Inspection Observation and Reiterates Anticipated Readiness for Mid-Year Re-Inspection Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that the U.S. Food...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a first quarter dividend of $0.10 per share on outstanding common stock. The...

Company Achieves CE Mark Approval Ahead of Schedule; XIENCE V Launch Slated for Second Quarter Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...

Earnings from continuing operations of $85 million or $0.25 per share compared to guidance of $0.17-$0.23 per share Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the...

Cancels Special Meeting of Shareholders; Enters Into Agreement with Boston Scientific Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has terminated its merger...

Natick, MA and Indianapolis, IN - Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Board of Directors of Guidant has unanimously approved and...

Company Has Successfully Completed Conformity Assessment and Facility Audit by Notified Body; CE Mark Certificate Expected in 7-10 Days Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE:...

ndianapolis, Ind. - Guidant Corporation (NYSE: GDT) is voluntarily advising and updating physicians about important safety information regarding certain older model pacemakers. This communication...

Guidant''s Board to Evaluate Offer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt today, , of an amended offer from Boston Scientific Corporation to acquire Guidant for...